Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Friday, January 8, 2010, 10:23PM AEST - The Australian Stockmarket is closed.
To create a watchlist or portfolio of shares,
Register
FINANCE HOME PAGE
INVESTING
FINANCE NEWS
PERSONAL FINANCE
SMALL BUSINESS
Enter symbol(s):
Symbol Lookup
|
Exchanges
Search News:
AP Pharma Inc. (APPA)
8:00AM AEST:
1.41 USD
0.00 (0.00%)
MORE ON APPA
Quotes
Summary
Options
Historical Prices
Charts
Basic Chart
Technical Chart
Technical Analysis
Detailed Data
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
A.P. Pharma, Inc.
(NCM:APPA) Delayed quote data
Last Trade:
1.41 USD
Trade Time:
8:00AM AEST
Change:
0.00 (0.00%)
Prev Close:
1.41
Open:
N/A
Bid:
0.90
x 100
Ask:
N/A
1y Target Est:
2.50
Day's Range:
N/A - N/A
52wk Range:
0.38 - 1.40
Volume:
0
Avg Vol
(3m)
:
94,133.3
Market Cap:
55.52M
P/E
(ttm)
:
N/A
EPS
(ttm)
:
-0.39
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
max
Add APPA to Portfolio
Download Data
HEADLINES
AP PHARMA INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
EDGAR Online
(Wed, Nov 25)
A.P. Pharma Receives Notice of Compliance with Nasdaq Continued Listing Requirements
Business Wire
(Mon, Nov 23)
AP PHARMA INC /DE/ Financials
EDGAR Online Financials
(Sat, Nov 21)
AP PHARMA INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online
(Tue, Nov 17)
AP PHARMA INC /DE/ Files SEC form 10-Q, Quarterly Report
EDGAR Online
(Tue, Nov 17)
A.P. Pharma Q3 loss narrows to $1.2M
at bizjournals.com
(Tue, Nov 17)
A.P. Pharma Reports Third Quarter 2009 Financial Results
Business Wire
(Mon, Nov 16)
AP PHARMA INC /DE/ Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
EDGAR Online
(Thu, Oct 29)
A.P. Pharma to Transfer to Nasdaq Capital Market
Business Wire
(Wed, Oct 28)
AP PHARMA INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securi
EDGAR Online
(Fri, Oct 23)
More Headlines for APPA...
ANALYST
EPS Est (next year)
(Dec-09)
:
N/A
EPS Est (in 2 years)
(Dec-10)
:
N/A
Avg Rec (current)*:
1.0
PEG Ratio:
N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
A.P. Pharma, Inc., a specialty pharmaceutical company, engages in developing pharmaceutical products using its proprietary Biochronomer polymer-based drug delivery technology.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Australia
New Zealand
US
----------------
Argentina
Austria
Brazil
Canada - Toronto
Canada - Vancouver
China - Shanghai
China - Shenzhen
Denmark
France
Germany XETRA
Germany - Berlin
Hong Kong
India - Bombay
India - National
Indonesia
Israel
Italy
Malaysia
Mexico
Netherlands
Norway
Singapore
South Korea - Korea
South Korea - KOSDAQ
Spain
Sweden
Switzerland
Taiwan OTC
Taiwan
Thailand
United Kingdom
Symbol Lookup
Latest News
7 Indices